176 related articles for article (PubMed ID: 1471600)
1. Angiotensin-converting enzyme inhibitors as cardioprotective agents.
Massie BM
Am J Cardiol; 1992 Dec; 70(21):10I-17I. PubMed ID: 1471600
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection with angiotensin-converting enzyme inhibitors: redefined for the 1990s.
Kloner RA; Przyklenk K
Clin Cardiol; 1993 Feb; 16(2):95-103. PubMed ID: 8435934
[TBL] [Abstract][Full Text] [Related]
3. [Angiotensin converting enzyme inhibitors in arterial hypertension].
Ramón González-Juanatey J
Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
Beckwith C; Munger MA
Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection and ACE inhibitors.
Ball SG
Clin Physiol Biochem; 1992; 9(3):98-104. PubMed ID: 1302164
[TBL] [Abstract][Full Text] [Related]
6. When to start an ACE inhibitor and in whom.
Wilson PA
Cardiovasc Drugs Ther; 1994 Feb; 8(1):111-4. PubMed ID: 8086320
[No Abstract] [Full Text] [Related]
7. Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins.
Tschöpe C; Gohlke P; Zhu YZ; Linz W; Schölkens B; Unger T
J Card Fail; 1997 Jun; 3(2):133-48. PubMed ID: 9220313
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
Ferrari R; Ceconi C; Curello S; Pepi P; Mazzoletti A; Visioli O
Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():639-47. PubMed ID: 9115958
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibitors: myocardial infarction and congestive heart failure.
Cody RJ
Am Fam Physician; 1995 Nov; 52(6):1801-6. PubMed ID: 7484690
[TBL] [Abstract][Full Text] [Related]
10. Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Krakoff LR; Rajasekharaiah V
Mt Sinai J Med; 1998 Mar; 65(2):125-32. PubMed ID: 9520516
[No Abstract] [Full Text] [Related]
11. Contribution of bradykinin to the cardioprotective action of angiotensin converting enzyme inhibition in hypertension and after myocardial infarction.
Ito K; Zhu YZ; Zhu YC; Gohlke P; Unger T
Jpn J Pharmacol; 1997 Dec; 75(4):311-8. PubMed ID: 9469636
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications for therapy: possible cardioprotective effects of ACE inhibition.
Dzau VJ
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):183S-187S. PubMed ID: 2690909
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
14. [ACE-inhibitors and cardiovascular protection].
Agabiti-Rosei E; Muiesan ML
Cardiologia; 1994 Dec; 39(12 Suppl 1):139-47. PubMed ID: 7634257
[TBL] [Abstract][Full Text] [Related]
15. Current indications for ACE inhibitors and HOPE for the future.
Burch S; Ou N
Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective potential of angiotensin-converting enzyme inhibitors.
Gavras I; Gavras H
Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV68-71; discussion IV83-90. PubMed ID: 1893645
[TBL] [Abstract][Full Text] [Related]
17. Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors.
Zhu YC; Stauss HM; Bao G; Gohlke P; Zhu YZ; Redlich T; Unger T
Can J Physiol Pharmacol; 1995 Jul; 73(7):827-31. PubMed ID: 8846416
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure.
McKelvie R; McConachie D; Yusuf S
Eur Heart J; 1994 May; 15 Suppl B():9-13; discussion 26-30. PubMed ID: 8076660
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective potential of angiotensin converting enzyme inhibitors.
Gavras I; Gavras H
Braz J Med Biol Res; 1996 Jun; 29(6):701-5. PubMed ID: 9070382
[TBL] [Abstract][Full Text] [Related]
20. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
